Drugs Approved for Bladder Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for bladder cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in bladder cancer that are not listed here.

Drugs Approved for Bladder Cancer

Adstiladrin (Nadofaragene Firadenovec-vncg)
Anktiva (Nogapendekin Alfa Inbakicept-pmln)
Avelumab
Balversa (Erdafitinib)
Bavencio (Avelumab)
Cisplatin
Doxorubicin Hydrochloride
Durvalumab
Enfortumab Vedotin-ejfv
Erdafitinib
Imfinzi (Durvalumab)
Jelmyto (Mitomycin)
Keytruda (Pembrolizumab)
Mitomycin
Nadofaragene Firadenovec-vncg
Nivolumab
Nivolumab and Hyaluronidase-nvhy
Nogapendekin Alfa Inbakicept-pmln
Opdivo (Nivolumab)
Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
Padcev (Enfortumab Vedotin-ejfv)
Pemazyre (Pemigatinib)
Pembrolizumab
Pemigatinib
Tepadina (Thiotepa)
Thiotepa
Valrubicin
Valstar (Valrubicin)

Drug Combinations Used in Bladder Cancer

GEMCITABINE-CISPLATIN
MVAC